Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation.

[1]  F. Cheney,et al.  Reperfusion of ischemic dog lung results in fever, leukopenia, and lung edema. , 2015, The American review of respiratory disease.

[2]  N. Coe.  The Physiologic Basis of Surgery , 1997 .

[3]  J. T. Cope,et al.  Euro-Collins solution exacerbates lung injury in the setting of high-flow reperfusion. , 1996, The Journal of thoracic and cardiovascular surgery.

[4]  C. Tribble,et al.  Enhanced isolated lung function after ischemia with anti-intercellular adhesion molecule antibody. , 1996, The Journal of thoracic and cardiovascular surgery.

[5]  J. T. Cope,et al.  Pulmonary function after non-heart-beating lung donation in a survival model. , 1995, The Annals of thoracic surgery.

[6]  H. Matsuda,et al.  Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. , 1994, The Journal of thoracic and cardiovascular surgery.

[7]  Xiao‐Kang Li,et al.  EFFECT OF PROTEASE INHIBITOR ON ISCHEMIA/REPERFUSION INJURY OF THE RAT LIVER , 1993, Transplantation.

[8]  M. Yoshida,et al.  The inhibitory actions of protease inhibitors on the production of polymorphonuclear leukocyte elastase and interleukin 8. , 1993, Research communications in chemical pathology and pharmacology.

[9]  T. Aoki,et al.  Use of ulinastatin for improving the viability of liver grafts. , 1993, Transplantation proceedings.

[10]  T. Horiguchi,et al.  THE EFFECT OF PROTEASE INHIBITOR ON REPERFUSION INJURY AFTER UNILATERAL PULMONARY ISCHEMIA , 1993, Transplantation.

[11]  W. Baumgartner,et al.  Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. , 1992, The Journal of thoracic and cardiovascular surgery.

[12]  M. Arakawa,et al.  Effects of ulinastatin, an antiprotease, on alloxan-induced lung injury in dogs. , 1992, Clinical therapeutics.

[13]  A. Malik,et al.  Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. , 1990, The American journal of physiology.

[14]  W. Baumgartner,et al.  Leukocyte depletion results in excellent heart-lung function after 12 hours of storage. , 1990, The Annals of thoracic surgery.

[15]  J. Hoidal,et al.  Role of reactive oxygen species in reperfusion injury of the rabbit lung. , 1989, The Journal of clinical investigation.

[16]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[17]  W. Baumgartner,et al.  The role of leukocyte depletion in reducing injury to the lung after hypothermic ischemia. , 1987, Current surgery.

[18]  W. Baumgartner,et al.  Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. , 1995, The Annals of thoracic surgery.

[19]  A. M. Lefer,et al.  Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. , 1993, Annual review of pharmacology and toxicology.

[20]  Y. Yamanaka,et al.  Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats. , 1992, Japanese journal of pharmacology.